Molecular mechanisms of curcumin on diabetes-induced endothelial dysfunctions: Txnip, ICAM-1, and NOX2 expressions

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Wongeakin, Natchaya ^a   Bhattarakosol, Parvapan ^a   Patumraj, Suthiluk ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CURCUMIN; GLUCOSE; HEMOGLOBIN A1C; INTERCELLULAR ADHESION MOLECULE 1; MALONALDEHYDE; PROTEIN P47; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; THIOBARBITURIC ACID REACTIVE SUBSTANCE; THIOREDOXIN INTERACTING PROTEIN; CARRIER PROTEIN; CYBB PROTEIN, RAT; GLUCOSE BLOOD LEVEL; MEMBRANE PROTEIN; NEUTROPHIL CYTOSOLIC FACTOR 1; OXYGEN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TXNIP PROTEIN, RAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; FLUORESCENCE MICROSCOPY; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; LASER DOPPLER FLOWMETRY; LEUKOCYTE ADHERENCE; LIPID PEROXIDATION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; VENULE; WESTERN BLOTTING; ANIMAL; CELL ADHESION; CHEMISTRY; CYTOLOGY; DIABETES COMPLICATIONS; DOPPLER FLOWMETRY; GENE EXPRESSION REGULATION; LEUKOCYTE; METABOLISM; PERFUSION; WISTAR RAT;

ANIMALS; BLOOD GLUCOSE; CARRIER PROTEINS; CELL ADHESION; CURCUMIN; DIABETES COMPLICATIONS; GENE EXPRESSION REGULATION; INTERCELLULAR ADHESION MOLECULE-1; LEUKOCYTES; MALE; MALONDIALDEHYDE; MEMBRANE GLYCOPROTEINS; MICROSCOPY, CONFOCAL; NADPH OXIDASE; OXYGEN; PERFUSION; RATS; RATS, WISTAR; ULTRASONOGRAPHY, DOPPLER;

EID: 84904089052     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/161346     Document Type: Article

References (60)

1. Fatehi-Hassanabad Z., Chan C. B., Furman B. L., Reactive oxygen species and endothelial function in diabetes. European Journal of Pharmacology 2010 636 1-3 8 17 10.1016/j.ejphar.2010.03.048 2-s2.0-77952675536
2. Perez-Matute P., Zulet M. A., Martinez J. A., Reactive species and diabetes: counteracting oxidative stress to improve health. Current Opinion in Pharmacology 2009 9 6 771 779 10.1016/j.coph.2009.08.005 2-s2.0-70449469039
3. Soldatos G., Cooper M. E., Diabetic nephropathy: important pathophysiologic mechanisms. Diabetes Research and Clinical Practice 2008 82 supplement 1 S75 S79 10.1016/j.diabres.2008.09.042 2-s2.0-55249114365
4. Turrens J. F., Mitochondrial formation of reactive oxygen species. The Journal of Physiology 2003 552, part 2 335 344 10.1113/jphysiol.2003.049478 2-s2.0-0142150051 (Pubitemid 37321833)
5. Schulze P. C., Liu H., Choe E., Yoshioka J., Shalev A., Bloch K. D., Lee R. T., Nitric oxide-dependent suppression of thioredoxin-interacting protein expression enhances thioredoxin activity. Arteriosclerosis, Thrombosis, and Vascular Biology 2006 26 12 2666 2672 10.1161/01.ATV.0000248914.21018.f1 2-s2.0-33751186323
6. Schulze P. C., Yoshioka J., Takahashi T., He Z., King G. L., Lee R. T., Hyperglycemia promotes oxidative stress through inhibition of thioredoxin function by thioredoxin-interacting protein. The Journal of Biological Chemistry 2004 279 29 30369 30374 10.1074/jbc.M400549200 2-s2.0-3142751251 (Pubitemid 38937964)
7. Li X., Rong Y., Zhang M., Wang X. L., LeMaire S. A., Coselli J. S., Zhang Y., Shen Y. H., Up-regulation of thioredoxin interacting protein (Txnip) by p38 MAPK and FOXO1 contributes to the impaired thioredoxin activity and increased ROS in glucose-treated endothelial cells. Biochemical and Biophysical Research Communications 2009 381 4 660 665 10.1016/j.bbrc.2009.02.132 2-s2.0-62949147248
8. 4 acetylation in pancreatic beta cells. The Journal of Biological Chemistry 2009 284 25 16898 16905 10.1074/jbc.M109. 010504 2-s2.0-67650544980
9. Nishiyama A., Matsui M., Iwata S., Hirota K., Masutani H., Nakamura H., Takagi Y., Sono H., Gon Y., Yodoi J., Identification of thioredoxin-binding protein-2/vitamin D3 up-regulated protein 1 as a negative regulator of thioredoxin function and expression. Journal of Biological Chemistry 1999 274 31 21645 21650 10.1074/jbc.274.31.21645 2-s2.0-0033618398 (Pubitemid 29359988)
10. Junn E., Han S. H., Im J. Y., Yang Y., Cho E. W., Um H. D., Kim D. K., Lee K. W., Han P. L., Rhee S. G., Choi I., Vitamin D3 up-regulated protein 1 mediates oxidative stress via suppressing the thioredoxin function. Journal of Immunology 2000 164 12 6287 6295 10.4049/jimmunol.164.12.6287 2-s2.0-0034658976 (Pubitemid 30408809)
11. Spindel O. N., World C., Berk B. C., Thioredoxin interacting protein: redox dependent and independent regulatory mechanisms. Antioxidants & Redox Signaling 2012 16 6 587 596 10.1089/ars.2011.4137 2-s2.0-84856756649
12. Harrison C. B., Drummond G. R., Sobey C. G., Selemidis S., Evidence that nitric oxide inhibits vascular inflammation and superoxide production via a p47phox-dependent mechanism in mice. Clinical and Experimental Pharmacology and Physiology 2010 37 4 429 434 10.1111/j.1440-1681.2009.05317.x 2-s2.0-77949900768
13. Yamawaki H., Berk B. C., Thioredoxin: a multifunctional antioxidant enzyme in kidney, heart and vessels. Current Opinion in Nephrology & Hypertension 2005 14 2 149 153 10.1097/00041552-200503000-00010 2-s2.0-15444377306 (Pubitemid 40396868)
14. Yamawaki H., Pan S., Lee R. T., Berk B. C., Fluid shear stress inhibits vascular inflammation by decreasing thioredoxin-interacting protein in endothelial cells. Journal of Clinical Investigation 2005 115 3 733 738 10.1172/JCI200523001 2-s2.0-14644401702 (Pubitemid 40322249)
15. Perrone L., Devi T. S., Hosoya K., Terasaki T., Singh L. P., Thioredoxin interacting protein (TXNIP) induces inflammation through chromatin modification in retinal capillary endothelial cells under diabetic conditions. Journal of Cellular Physiology 2009 221 1 262 272 10.1002/jcp.21852 2-s2.0-69249226353
16. Perrone L., Devi T. S., Hosoya K. I., Terasaki T., Singh L. P., Inhibition of TXNIP expression in vivo blocks early pathologies of diabetic retinopathy. Cell Death & Disease 2010 1 8, article e65 10.1038/cddis.2010. 42 2-s2.0-79958859597
17. Szabo M. E., Droy-Lefaix M. T., Doly M., Braquet P., Free radical-mediated effects in reperfusion injury: a histologic study with superoxide dismutase and EGB 761 in rat retina. Ophthalmic Research 1991 23 4 225 234 10.1159/000267107 2-s2.0-0025787288
18. Omori K., Ohira T., Uchida Y., Ayilavarapu S., Batista E. L. Jr., Yagi M., Iwata T., Liu H., Hasturk H., Kantarci A., Van Dyke T. E., Priming of neutrophil oxidative burst in diabetes requires preassembly of the NADPH oxidase. Journal of Leukocyte Biology 2008 84 1 292 301 10.1189/jlb.1207832 2-s2.0-46949098600 (Pubitemid 351960304)
19. Al-Shabrawey M., Rojas M., Sanders T., Behzadian A., El-Remessy A., Bartoli M., Parpia A. K., Liou G., Caldwell R. B., Role of NADPH oxidase in retinal vascular inflammation. Investigative Ophthalmology & Visual Science 2008 49 7 3239 3244 10.1167/iovs.08-1755 2-s2.0-48249134698
20. Jain S. K., Rains J., Jones K., Effect of curcumin on protein glycosylation, lipid peroxidation, and oxygen radical generation in human red blood cells exposed to high glucose levels. Free Radical Biology & Medicine 2006 41 1 92 96 10.1016/j.freeradbiomed.2006.03.008 2-s2.0-33744979960 (Pubitemid 43866454)
21. Kowluru R. A., Kanwar M., Effects of curcumin on retinal oxidative stress and inflammation in diabetes. Nutrition and Metabolism 2007 4, article 8 10.1186/1743-7075-4-8 2-s2.0-34247542013 (Pubitemid 46663082)
22. Meghana K., Sanjeev G., Ramesh B., Curcumin prevents streptozotocin- induced islet damage by scavenging free radicals: a prophylactic and protective role. European Journal of Pharmacology 2007 577 1-3 183 191 10.1016/j.ejphar. 2007.09.002 2-s2.0-35448932469 (Pubitemid 47632529)
23. Kanitkar M., Bhonde R. R., Curcumin treatment enhances islet recovery by induction of heat shock response proteins, Hsp70 and heme oxygenase-1, during cryopreservation. Life Sciences 2008 82 3-4 182 189 10.1016/j.lfs.2007.10.026 2-s2.0-37549011770
24. Mandal M. N. A., Patlolla J. M. R., Zheng L., Agbaga M., Tran J. A., Wicker L., Kasus-Jacobi A., Elliott M. H., Rao C. V., Anderson R. E., Curcumin protects retinal cells from light-and oxidant stress-induced cell death. Free Radical Biology & Medicine 2009 46 5 672 679 10.1016/j.freeradbiomed.2008. 12.006 2-s2.0-59249104565
25. Jung K.-A., Kwak M.-K., The Nrf2 system as a potential target for the development of indirect antioxidants. Molecules 2010 15 10 7266 7291 10.3390/molecules15107266 2-s2.0-78149434112
26. Molina-Jijón E., Tapia E., Zazueta C., El Hafidi M., Zatarain-Barrón Z. L., Hernández-Pando R., Medina-Campos O. N., Zarco-Márquez G., Torres I., Pedraza-Chaverri J., Curcumin prevents Cr(VI)-induced renal oxidant damage by a mitochondrial pathway. Free Radical Biology and Medicine 2011 51 8 1543 1557 10.1016/j.freeradbiomed.2011.07.018 2-s2.0-84860389335
27. Gao X., Kuo J., Jiang H., Deeb D., Liu Y., Divine G., Chapman R. A., Dulchavsky S. A., Gautam S. C., Immunomodulatory activity of curcumin: suppression of lymphocyte proliferation, development of cell-mediated cytotoxicity, and cytokine production in vitro. Biochemical Pharmacology 2004 68 1 51 61 10.1016/j.bcp.2004.03.015 2-s2.0-2942624044 (Pubitemid 38746541)
28. Binion D. G., Heidemann J., Li M. S., Nelson V. M., Otterson M. F., Rafiee P., Vascular cell adhesion molecule-1 expression in human intestinal microvascular endothelial cells is regulated by PI 3-kinase/Akt/MAPK/NF- B: inhibitory role of curcumin. American Journal of Physiology: Gastrointestinal and Liver Physiology 2009 297 2 G259 G268 10.1152/ajpgi.00087.2009 2-s2.0-68049083799
29. 6] sensitizes human prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L-induced apoptosis by suppressing nuclear factor- B via inhibition of the prosurvival Akt signaling pathway. The Journal of Pharmacology and Experimental Therapeutics 2007 321 2 616 625 10.1124/jpet.106.117721 2-s2.0-34247229225 (Pubitemid 46624498)
30. Banerjee M., Tripathi L. M., Srivastava V. M. L., Puri A., Shukla R., Modulation of inflammatory mediators by ibuprofen and curcumin treatment during chronic inflammation in rat. Immunopharmacology and Immunotoxicology 2003 25 2 213 224 10.1081/IPH-120020471 2-s2.0-0037908832 (Pubitemid 36597418)
31. Kumar A., Dhawan S., Hardegen N. J., Aggarwal B. B., Curcumin (diferuloylmethane) inhibition of tumor necrosis factor (TNF)- mediated adhesion of monocytes to endothelial cells by suppression of cell surface expression of adhesion molecules and of nuclear factor- B activation. Biochemical Pharmacology 1998 55 6 775 783 10.1016/S0006-2952(97)00557-1 2-s2.0-0032520716 (Pubitemid 28319640)
32. Gupta B., Ghosh B., Curcuma longa inhibits TNF- α induced expression of adhesion molecules on human umbilical vein endothelial cells. International Journal of Immunopharmacology 1999 21 11 745 757 10.1016/S0192-0561(99)00050-8 2-s2.0-0032821829 (Pubitemid 29472502)
33. Patumraj S., Wongeakin N., Sridulyakul P., Jariyapongskul A., Futrakul N., Bunnag S., Combined effects of curcumin and vitamin C to protect endothelial dysfunction in the iris tissue of STZ-induced diabetic rats. Clinical Hemorheology and Microcirculation 2006 35 4 481 489 2-s2.0-33751357523 (Pubitemid 44812461)
34. Wongeakin N., Sridulyakul P., Jariyapongskul A., Futrakula N., Bunnag S. C., Patumraj S., Effects of curcumin and tetrahydrocurcumin on stz-induced diabetic rats. Journal of Vascular Research 2006 43 32
35. American Diabetes Association, Diagnosis and classification of diabetes mellitus. Diabetes Care 2011 34 supplement 1 S62 S69 10.2337/dc11-S062
36. Bandello F., Brancato R., Lattanzio R., Galdini M., Falcomata B., Relation between iridopathy and retinopathy in diabetes. British Journal of Ophthalmology 1994 78 7 542 545 10.1136/bjo.78.7.542 2-s2.0-0028303654 (Pubitemid 24213013)
37. Jariyapongskul A., Rungjaroen T., Kasetsuwan N., Patumraj S., Seki J., Niimi H., Long-term effects of oral vitamin C supplementation on the endothelial dysfunction in the iris microvessels of diabetic rats. Microvascular Research 2007 74 1 32 38 10.1016/j.mvr.2007.03.002 2-s2.0-34249801211 (Pubitemid 46855790)
38. Stuehmer C., Schumann P., Bormann K., Laschke M. W., Menger M. D., Gellrich N., Rücker M., A new model for chronic in vivo analysis of the periosteal microcirculation. Microvascular Research 2009 77 2 104 108 10.1016/j.mvr.2008.09.008 2-s2.0-60449118663
39. Saetzler R. K., Jallo J., Lehr H. A., Philips C. M., Vasthare U., Arfors K. E., Tuma R. F., Intravital fluorescence microscopy: impact of light-induced phototoxicity on adhesion of fluorescently labeled leukocytes. Journal of Histochemistry and Cytochemistry 1997 45 4 505 513 10.1177/002215549704500403 2-s2.0-0031002858 (Pubitemid 27175795)
40. Byfield G., Budd S., Hartnett M. E., The role of supplemental oxygen and JAK/STAT signaling in intravitreous neovascularization in a ROP rat model. Investigative Ophthalmology & Visual Science 2009 50 7 3360 3365 10.1167/iovs.08-3256 2-s2.0-67649948987
41. Trichonas G., Manola A., Morizane Y., Thanos A., Koufomichali X., Papakostas T. D., Montezuma S., Young L., Miller J. W., Gragoudas E., Vavvas D., A novel nonradioactive method to evaluate vascular barrier breakdown and leakage. Investigative Ophthalmology & Visual Science 2010 51 3 1677 1682 10.1167/iovs.09-4193 2-s2.0-77949888782
42. Ohkawa H., Ohishi N., Yagi K., Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Analytical Biochemistry 1979 95 2 351 358 10.1016/0003-2697(79)90738-3 2-s2.0-0018384650 (Pubitemid 9194347)
43. Chen L., Zhang J., Zhang Y., Wang Y., Wang B., Improvement of inflammatory responses associated with NF- B pathway in kidneys from diabetic rats. Inflammation Research 2008 57 5 199 204 10.1007/s00011-006-6190-z 2-s2.0-46449103466
44. Shelev A., Lack of TXNIP protects β -cells against glucotoxicity. Biochemical Society Transactions 2008 36, part 5 963 965 10.1042/BST0360963 2-s2.0-53849116110
45. Rungseesantivanon S., Thenchaisri N., Ruangvejvorachai P., Patumraj S., Curcumin supplementation could improve diabetes-induced endothelial dysfunction associated with decreased vascular superoxide production and PKC inhibition. BMC Complementary and Alternative Medicine 2010 10, article 57 10.1186/1472-6882- 10-57 2-s2.0-77957765255
46. Rungseesantivanon S., Thengchaisri N., Ruangvejvorachai P., Patumraj S., Curcumin improves prostanoid ratio in diabetic mesenteric arteries associated with cyclooxygenase-2 and NF-kappaB suppression. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010 3 421 429
47. Seo K., Choi M., Jung U. J., Kim H., Yeo J., Jeon S., Lee M., Effect of curcumin supplementation on blood glucose, plasma insulin, and glucose homeostasis related enzyme activities in diabetic db/db mice. Molecular Nutrition and Food Research 2008 52 9 995 1004 10.1002/mnfr.200700184 2-s2.0-54949119528
48. Suryanarayana P., Saraswat M., Mrudula T., Krishna T. P., Krishnaswamy K., Reddy G. B., Curcumin and turmeric delay streptozotocin-induced diabetic cataract in rats. Investigative Ophthalmology & Visual Science 2005 46 6 2092 2099 10.1167/iovs.04-1304 2-s2.0-22144432295
49. Chanpoo M., Petchpiboonthai H., Panyarachun B., Anupunpisit V., Effect of curcumin in the amelioration of pancreatic islets in streptozotocin-induced diabetic mice. Journal of the Medical Association of Thailand 2010 93 supplement 6 S152 S159 2-s2.0-84855494579
50. Nam S. M., Lee M. Y., Koh J. H., Park J. H., Shin J. Y., Shin Y. G., Koh S. B., Lee E. Y., Chung C. H., Effects of NADPH oxidase inhibitor on diabetic nephropathy in OLETF rats: the role of reducing oxidative stress in its protective property. Diabetes Research and Clinical Practice 2009 83 2 176 182 10.1016/j.diabres.2008.10.007 2-s2.0-58249119832
51. Awasthi H., Tota S., Hanif K., Nath C., Shukla R., Protective effect of curcumin against intracerebral streptozotocin induced impairment in memory and cerebral blood flow. Life Sciences 2010 86 3-4 87 94 10.1016/j.lfs.2009.11.007 2-s2.0-73549106545
52. Gupta S. K., Kumar B., Nag T. C., Agrawal S. S., Agrawal R., Agrawal P., Saxena R., Srivastava S., Curcumin prevents experimental diabetic retinopathy in rats through its hypoglycemic, antioxidant, and anti-inflammatory mechanisms. Journal of Ocular Pharmacology and Therapeutics 2011 27 2 123 130 10.1089/jop.2010.0123 2-s2.0-79955008744
53. Menon V. P., Sudheer A. R., Antioxidant and anti-inflammatory properties of curcumin. Advances in Experimental Medicine and Biology 2007 595 105 125 10.1007/978-0-387-46401-5-3 2-s2.0-34347221933
54. Joussen A. M., Poulaki V., Le M. L., Koizumi K., Esser C., Janicki H., Schraermeyer U., Kociok N., Fauser S., Kirchhof B., Kern T. S., Adamis A. P., A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB Journal 2004 18 12 1450 1452 10.1096/fj.03-1476fje 2-s2.0-7044228789 (Pubitemid 39561611)
55. Pemp B., Schmetterer L., Ocular blood flow in diabetes and age-related macular degeneration. Canadian Journal of Ophthalmology 2008 43 3 295 301 10.1139/I08-049 2-s2.0-47549083707
56. Aoki H., Takada Y., Kondo S., Sawaya R., Aggarwal B. B., Kondo Y., Evidence that curcumin suppresses the growth of malignant gliomas in vitro and in vivo through induction of autophagy: role of akt and extracellular signal-regulated kinase signaling pathways. Molecular Pharmacology 2007 72 1 29 39 10.1124/mol.106.033167 2-s2.0-34347238938 (Pubitemid 46998522)
57. Yang J., Lane P. H., Pollock J. S., Carmines P. K., Protein kinase C-dependent NAD(P)H oxidase activation induced by type 1 diabetes in renal medullary thick ascending limb. Hypertension 2010 55 2 468 473 10.1161/HYPERTENSIONAHA.109.145714 2-s2.0-74949119895
58. Asaba K., Tojo A., Onozato M. L., Goto A., Quinn M. T., Fujita T., Wilcox C. S., Effects of NADPH oxidase inhibitor in diabetic nephropathy. Kidney International 2005 67 5 1890 1898 10.1111/j.1523-1755.2005.00287.x 2-s2.0-17744364508 (Pubitemid 40577724)
59. Tsai K. H., Wang W. J., Lin C. W., Pai P. Y., Lai T. Y., Tsai C. Y., Kuo W., NADPH oxidase-derived superoxide Anion-induced apoptosis is mediated via the JNK-dependent activation of NF- κ B in cardiomyocytes exposed to high glucose. Journal of Cellular Physiology 2012 227 4 1347 1357 10.1002/jcp.22847 2-s2.0-84862930802
60. Szabó A., Farkas A., Vámos R., Bajor T., Hrabák A., The inhibition of retinal inducible nitric oxide synthase overexpression and the attenuation of experimental uveitis by anti-inflammatory drugs in rats. Inflammation Research 2004 53 6 262 267 10.1007/s00011-004-1259-z 2-s2.0-2942726597 (Pubitemid 38797564)